Shanghai Rightongene Biotechnology Co.Ltd(688217)
Performance report of the audit committee of the board of directors in 2021
According to the company law of the people’s Republic of China, the securities law of the people’s Republic of China and the governance of listed companies
Guidelines, listing rules of Shanghai Stock Exchange on the science and innovation board and listing on the science and Innovation Board of Shanghai Stock Exchange
The provisions of the company’s self regulatory guidelines No. 1 – standardized operation and other relevant normative documents, as well as the company’s self regulatory guidelines
The relevant provisions of the articles of association and the company’s detailed rules for the work of the audit committee of the board of directors are hereby incorporated into Shanghai Shanghai Rightongene Biotechnology Co.Ltd(688217) section
The audit committee of the board of directors (hereinafter referred to as the “Audit Committee”) of the Technology Co., Ltd. (hereinafter referred to as the “company”)
The performance report of the board of directors in 2021 is as follows:
1、 Basic information of the audit committee
During the reporting period, the audit committee of the first board of directors of the company was composed of three members, namely independent directors
Mr. Yuan Xuewei, Mr. Xu Weijian and Ms. Zhao Guiying, among which the convener is Mr. Yuan Xuewei, an accounting professional
to serve as.
In December 2021, the board of directors of the company completed the replacement work and determined the audit committee of the new board of directors
The members of the board are still composed of independent directors Mr. Yuan Xuewei, Mr. Xu Weijian and Ms. Zhao Guiying
The second session of the audit committee of the board of directors, in which the convener is Mr. Yuan Xuewei, an accounting professional, whose term of office is the same as
The term of office of the current board of directors is the same.
2、 Meetings of the audit committee
In 2021, the audit committee of the board of directors of the company held 6 meetings, as follows:
Date of the meeting and resolutions on matters considered
Deliberating the proposal on the annual work report of the audit committee and the proposal on
Proposal on financial final accounts in 2020 and financial budget in 2021
The first board of directors
Proposal on financial statement and audit report in 2020
The audit committee first agreed to the 11th case and the confirmation of the company’s related party transactions in 2020
Tenth meeting
Proposal on estimating the related party transactions of the company in 2021
Proposal on renewing the appointment of the company’s audit institution in 2021
The first board of directors
April 2021
The audit committee reviewed the proposal on financial statements for the first quarter of 2021 and unanimously agreed on the 15th
Eleventh meeting
The first board of directors deliberated the proposal on the 2021 semi annual report and summary, and
August 2021
On the 20th day of the special unanimous agreement of the Audit Committee on the deposit and actual use of the raised funds in the half year of 2021
Proposal on the report of the 12th meeting
The first board of directors
September 2021
The Audit Committee deliberated the proposal on changing the head of the Audit Department of the company on the 24th and unanimously agreed
13th meeting 1st board of directors
October 2021
The Audit Committee deliberated the proposal on the company’s report and summary for the third quarter of 2021 and unanimously agreed on the 22nd
14th meeting 2nd board of directors
In December 2021, the meeting of the audit committee of the second board of directors on the election of Shanghai Rightongene Biotechnology Co.Ltd(688217) was reviewed
The audit committee first agreed to the proposal of the 7th person
One meeting
3、 Annual performance of the audit committee
1. Supervise and evaluate the work of external audit institutions
During the reporting period, the audit committee of the board of directors of the company carefully analyzed and evaluated the work of Zhonghui Certified Public Accountants (special general partnership) (hereinafter referred to as “Zhonghui certified public accountants”), who are qualified to engage in securities related business, follow independent, objective and impartial professional standards, and can better complete the audit work entrusted by the company. The personnel of Zhonghui accounting firm participating in the audit have the professional knowledge and relevant professional certificates necessary for the implementation of the audit. During the audit process, they are serious and responsible, maintain due attention and professional prudence, and are competent for the audit work of the company. The Audit Committee believes that Zhonghui certified public accountants has been able to fulfill its duties, follow the independent, objective and fair practice standards, and better fulfill the responsibilities and obligations of the audit institution.
2. Supervise and evaluate the company’s internal audit
During the reporting period, the audit committee of the board of directors gave full play to the role of the special committee. In accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the basic norms of enterprise internal control and other requirements, and in combination with the actual situation of the company, the audit committee carefully reviewed and inspected the company’s internal audit plan, urged the company to seriously implement it in accordance with the work plan and ensured the standardized operation of the company.
3. Review and comment on the company’s financial report
During the reporting period, the audit committee of the board of directors reviewed the financial reports of the company and communicated with the management of the company. It believed that the financial report of the company was true, accurate and complete, fairly reflected the financial status and operating results of the company, and there were no relevant fraud, fraud and major misstatement, no adjustment of major accounting errors, major changes in accounting policies and estimates, and matters involving important accounting judgments Matters leading to non-standard unqualified audit report, etc.
4. Supervise and evaluate the effectiveness of internal control
The company has established a relatively perfect corporate governance structure and governance system in accordance with the company law, securities law and other laws and regulations and the requirements of the relevant provisions of the CSRC and Shanghai Stock Exchange. During the reporting period, the company basically effectively implemented various laws, regulations, rules, articles of association and internal management systems, ensured the standardized operation of the general meeting of shareholders, the board of directors, the board of supervisors and the management, and effectively protected the legitimate rights and interests of the company and shareholders. 5. Coordinate the communication between management, internal audit department and relevant departments and external audit institutions
During the reporting period, the audit committee of the board of directors actively coordinated the company’s management, the audit department, the finance department and other relevant departments to maintain good communication with the external audit institutions. The relevant departments sought the opinions of the external audit institutions on the company’s financial accounting standards, the construction of internal control system and other issues, and cooperated with the external audit institutions to carry out the audit of annual financial reports, so as to promote the company’s financial and internal control standards.
6. Review of related party transactions and other matters of the company
During the reporting period, the audit committee reviewed the daily business related party transactions between the company and related parties, and considered that the daily related party transactions between the company and related parties in 2020 and the daily related party transactions expected in 2021 were required for normal business, followed the principles of openness, fairness and impartiality, and the transaction price was settled according to the market fair price, without any behavior damaging the interests of the company and shareholders, especially small and medium-sized investors, It does not affect the independence of the company.
4、 Overall evaluation
In 2021, the audit committee of the board of directors faithfully and diligently performed its duties specified in relevant laws and regulations, carefully considered relevant proposals, played a guiding, coordinating and supervising role, effectively promoted the construction of internal control and financial norms of the company, and promoted the standardized decision-making of the board of directors and standardized corporate governance.
In 2022, the audit committee of the board of directors will continue to earnestly perform its duties, strengthen the prior audit of relevant matters of the board of directors, strengthen the guidance of internal audit and the coordination of communication with external audit institutions, promote the standardization of financial related matters of the company, promote the construction of the company’s internal control system, and promote the standardized operation and steady development of the company.
It is hereby reported.
(no text below)
Shanghai Rightongene Biotechnology Co.Ltd(688217) board of directors audit committee April 18, 2022
